Folic Acid Isn't Working for You. Your Genes Might Explain Why.

MTHFR is the enzyme that converts both dietary folate and synthetic folic acid into methylfolate, the active form your cells actually use. This isn’t a minor step in your metabolism; it’s the entry point to the entire methylation cycle, the biochemical process that powers ATP production, neurotransmitter synthesis, DNA repair, and hormone metabolism.

The C677T variant, carried by roughly 40% of people with European ancestry, reduces this enzyme’s efficiency by 40-70%. That means your cells are processing dietary folate and folic acid at a fraction of the rate they should be. If you’re homozygous (two copies), the reduction is even steeper, and you’re at risk for functional folate deficiency even with normal blood levels.

You can eat a perfect diet and take folic acid supplements every day and still be functionally depleted of active folate at the cellular level. This shows up as fatigue that doesn’t respond to rest, persistent brain fog, mood instability, and difficulty getting pregnant despite normal bloodwork.

Your cells have receptors that recognize vitamin D and unlock its benefits. VDR is the gene that codes for this receptor. If you have certain VDR variants, your cells don’t recognize vitamin D as efficiently, even if your serum levels look adequate on blood work.

Common variants like BsmI and FokI, found in roughly 30-50% of the population, reduce the sensitivity and cellular uptake of vitamin D. You can take 2000 IU, 4000 IU, or even 5000 IU of vitamin D daily and still have cellular vitamin D deficiency. This is particularly problematic because vitamin D regulates your mitochondrial function and the genes involved in ATP production.

When VDR function is compromised, you experience fatigue that doesn’t respond to vitamin D supplementation at standard doses, impaired mood regulation, slower wound healing, and reduced immune resilience.

Vitamin D doesn’t float freely in your bloodstream; it’s bound to a transport protein called VDBP, which is coded by the GC gene. Different GC haplotypes change how tightly vitamin D is bound, determining how much free, bioavailable vitamin D reaches your tissues.

Some GC variants, particularly haplotype 2, bind vitamin D more tightly, which means less of your circulating vitamin D is available to your cells even though your total serum level looks normal on a blood test. Roughly 30-50% of the population carries a variant that shifts this balance. Your total vitamin D blood level can be 50 ng/mL, but if you have certain GC variants, your cells may only have access to the amount that someone else would have at 30 ng/mL.

This manifests as vitamin D insufficiency symptoms despite supplementation: low mood in winter, poor immune resilience, slower recovery from illness, and persistent bone or muscle aches.

You’ve been told to eat orange and yellow vegetables for vitamin A. BCMO1 is the enzyme that converts beta-carotene from those plants into retinol, the active form of vitamin A your cells actually need. Retinol is essential for gene expression, immune function, vision, and skin integrity.

Variants like R267S and A379V, found in roughly 45% of the population, reduce this enzyme’s conversion efficiency by 50% or more. You can eat twice the recommended amount of sweet potatoes, carrots, and spinach and still be functionally vitamin A-deficient if you carry a BCMO1 variant. Your bloodwork may show adequate beta-carotene levels, but your tissues aren’t actually converting it to the retinol they need.

This shows up as poor night vision, frequent infections, slow-healing skin, and hair that lacks shine and strength despite a nutrient-dense diet.

B6 (pyridoxine) must be converted into its active form, pyridoxal-5-phosphate, to function. NBPF3 variants affect this conversion and the overall metabolism of B6. Without adequate active B6, your body can’t synthesize neurotransmitters, regulate homocysteine, produce immune cells, or maintain healthy inflammation.

Variants like rs4654748, carried by roughly 30-40% of the population, are associated with lower pyridoxal-5-phosphate (active B6) levels even when dietary intake is adequate. Your body may be consuming B6 but unable to convert it to the active form fast enough to meet your metabolic needs. Standard bloodwork tests total B6, not the active form, so deficiency goes undetected.

You experience muscle cramps, mood instability, impaired wound healing, and a weakened ability to handle stress despite eating B6-rich foods.

COMT is the enzyme that breaks down dopamine, norepinephrine, and epinephrine once your body has used them. This clearance is critical: too slow and stress hormones stay elevated, keeping your nervous system in a state of activation. Too fast and you deplete dopamine, losing motivation and mood stability.

The Val158Met variant, found in roughly 25% of the population as homozygous slow metabolizers, means your body clears these neurotransmitters slowly. Even normal levels of stress or caffeine keep your dopamine and epinephrine elevated longer than they should, preventing your nervous system from downshifting into rest mode. This directly interferes with sleep quality and recovery, compounding any B vitamin or methylation issues.

You feel wired and tired simultaneously, sleep poorly despite being exhausted, feel jittery with caffeine or stimulants, and struggle to recover from stress or intense exercise.